“Cassava says that they have a drug candidate (Simufilam) for Alzheimer’s, but there’s good reason to believe that there are serious problems with that claim.”

Posted on by

Link. “Thirty-four papers by Cassava-associated scientists have come under scrutiny for research irregularities, and this led to a petition filing to the FDA asking that the company be investigated and their clinical trials halted”

Fraud.